86 related articles for article (PubMed ID: 9235982)
1. Inhibition of Lyn function in mast cell activation by SH3 domain binding peptides.
Stauffer TP; Martenson CH; Rider JE; Kay BK; Meyer T
Biochemistry; 1997 Aug; 36(31):9388-94. PubMed ID: 9235982
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after Fcepsilon receptor I aggregation.
Kovárová M; Tolar P; Arudchandran R; Dráberová L; Rivera J; Dráber P
Mol Cell Biol; 2001 Dec; 21(24):8318-28. PubMed ID: 11713268
[TBL] [Abstract][Full Text] [Related]
3. C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells.
Péterfy H; Tóth G; Pecht I; Erdei A
Int Immunol; 2008 Oct; 20(10):1239-45. PubMed ID: 18653698
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation-dependent and -independent associations of protein kinase C-delta with Src family kinases in the RBL-2H3 mast cell line: regulation of Src family kinase activity by protein kinase C-delta.
Song JS; Swann PG; Szallasi Z; Blank U; Blumberg PM; Rivera J
Oncogene; 1998 Jul; 16(26):3357-68. PubMed ID: 9692543
[TBL] [Abstract][Full Text] [Related]
5. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
6. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of AMPK through Lyn-Syk-Akt enhances FcεRI signal pathways for allergic response.
Lin KC; Huang DY; Huang DW; Tzeng SJ; Lin WW
J Mol Med (Berl); 2016 Feb; 94(2):183-94. PubMed ID: 26373430
[TBL] [Abstract][Full Text] [Related]
8. The interaction between Lyn and FcεRIβ is indispensable for FcεRI-mediated human mast cell activation.
Okayama Y; Kashiwakura JI; Matsuda A; Sasaki-Sakamoto T; Nunomura S; Yokoi N; Ebihara N; Kuroda K; Ohmori K; Saito H; Ra C
Allergy; 2012 Oct; 67(10):1241-9. PubMed ID: 22845063
[TBL] [Abstract][Full Text] [Related]
9. Overcoming the signaling defect of Lyn-sequestering, signal-curtailing FcepsilonRI dimers: aggregated dimers can dissociate from Lyn and form signaling complexes with Syk.
Lara M; Ortega E; Pecht I; Pfeiffer JR; Martinez AM; Lee RJ; Surviladze Z; Wilson BS; Oliver JM
J Immunol; 2001 Oct; 167(8):4329-37. PubMed ID: 11591756
[TBL] [Abstract][Full Text] [Related]
10. Roles for SH2 and SH3 domains in Lyn kinase association with activated FcepsilonRI in RBL mast cells revealed by patterned surface analysis.
Hammond S; Wagenknecht-Wiesner A; Veatch SL; Holowka D; Baird B
J Struct Biol; 2009 Oct; 168(1):161-7. PubMed ID: 19427382
[TBL] [Abstract][Full Text] [Related]
11. Scaffolding adapter Grb2-associated binder 2 requires Syk to transmit signals from FcepsilonRI.
Yu M; Lowell CA; Neel BG; Gu H
J Immunol; 2006 Feb; 176(4):2421-9. PubMed ID: 16456001
[TBL] [Abstract][Full Text] [Related]
12. Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase.
Maeno K; Sada K; Kyo S; Miah SM; Kawauchi-Kamata K; Qu X; Shi Y; Yamamura H
J Biol Chem; 2003 Jul; 278(27):24912-20. PubMed ID: 12709437
[TBL] [Abstract][Full Text] [Related]
13. SH2 domain-mediated targeting, but not localization, of Syk in the plasma membrane is critical for FcepsilonRI signaling.
Sada K; Zhang J; Siraganian RP
Blood; 2001 Mar; 97(5):1352-9. PubMed ID: 11222380
[TBL] [Abstract][Full Text] [Related]
14. Early activation of sphingosine kinase in mast cells and recruitment to FcepsilonRI are mediated by its interaction with Lyn kinase.
Urtz N; Olivera A; Bofill-Cardona E; Csonga R; Billich A; Mechtcheriakova D; Bornancin F; Woisetschläger M; Rivera J; Baumruker T
Mol Cell Biol; 2004 Oct; 24(19):8765-77. PubMed ID: 15367693
[TBL] [Abstract][Full Text] [Related]
15. Temporally resolved interactions between antigen-stimulated IgE receptors and Lyn kinase on living cells.
Larson DR; Gosse JA; Holowka DA; Baird BA; Webb WW
J Cell Biol; 2005 Nov; 171(3):527-36. PubMed ID: 16275755
[TBL] [Abstract][Full Text] [Related]
16. Sequential requirements of the N-terminal palmitoylation site and SH2 domain of Src family kinases in the initiation and progression of FcepsilonRI signaling.
Honda Zi; Suzuki T; Kono H; Okada M; Yamamoto T; Ra C; Morita Y; Yamamoto K
Mol Cell Biol; 2000 Mar; 20(5):1759-71. PubMed ID: 10669752
[TBL] [Abstract][Full Text] [Related]
17. Disruption of SLP-76 interaction with Gads inhibits dynamic clustering of SLP-76 and FcepsilonRI signaling in mast cells.
Silverman MA; Shoag J; Wu J; Koretzky GA
Mol Cell Biol; 2006 Mar; 26(5):1826-38. PubMed ID: 16479002
[TBL] [Abstract][Full Text] [Related]
18. Energetics of Src homology domain interactions in receptor tyrosine kinase-mediated signaling.
Ladbury JE; Arold ST
Methods Enzymol; 2011; 488():147-83. PubMed ID: 21195228
[TBL] [Abstract][Full Text] [Related]
19. Observing FcepsilonRI signaling from the inside of the mast cell membrane.
Wilson BS; Pfeiffer JR; Oliver JM
J Cell Biol; 2000 May; 149(5):1131-42. PubMed ID: 10831616
[TBL] [Abstract][Full Text] [Related]
20. TOM1L1 is a Lyn substrate involved in FcepsilonRI signaling in mast cells.
Zhang J; Suzuki K; Hitomi T; Siraganian RP
J Biol Chem; 2007 Dec; 282(52):37669-77. PubMed ID: 17977829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
